Search results

Showing results for

Recent graduate Ian Chai shares his experience of the MSc Radiobiology programme at the University of Oxford's Department of Oncology and how it helped to fuel his career aspirations.

Diagnostic Implications of Multi-Cancer Early Detection Testing in the Investigation of Cancer Symptoms: An Exploratory Retrospective Analysis of the SYMPLIFY Study.

Jackson A. et al, (2026), Lancet Reg Health Eur, 66

Pragmatism in academic gastrointestinal cancer clinical trials: An analysis of trials conducted by the EORTC gastrointestinal tract cancer group and the unicancer gastrointestinal group.

Puhr HC. et al, (2026), Eur J Cancer, 241

Post-adjuvant chemotherapy in ctDNA-positive patients with resected colorectal cancer: a randomized phase 3 trial.

Bando H. et al, (2026), Nat Med

First-line durvalumab in combination with trastuzumab deruxtecan in women with locally advanced unresectable or metastatic, hormone-receptor-negative, HER2-low breast cancer: multicenter, open-label, phase 1b/2 BEGONIA platform trial.

Schmid P. et al, (2026), Nat Cancer

Engineering and improving anti-CTLA-4 checkpoint inhibitors.

Galvez-Cancino F. et al, (2026), Clin Cancer Res

Critical Path to First-in-Human Batches of ChAdOx Vectors, Including for Emergency Response

Peralta Alvarez MP. et al, (2026), Vaccines, 14, 509 - 509

Nucleophagy removes cytotoxic trapped PARP1.

Hoslett G. et al, (2026), Nat Cell Biol

Real-world obesity prevalence and history in 79 271 patients receiving systemic anticancer therapy across 13 cancer types in England (2013-2023).

Perletta V. et al, (2026), ESMO Real World Data Digit Oncol, 12

Design and performance evaluation of a novel hybrid ionisation chamber and transmission calorimeter for dose rate independent beam monitoring in UHDR-RT

Flynn S. et al, (2026), Journal of Instrumentation, 21, P06001 - P06001

MAFF regulates ferroptotic sensitivity through iron homeostasis and fatty acid synthesis.

Vilaplana Lopera N. et al, (2026), Cell Death Dis

Effect of prior anti-EGFR therapy and baseline ctDNA profiling on the efficacy of pertuzumab plus trastuzumab in HER2-amplified metastatic colorectal cancer: an integrated analysis of TRIUMPH/MyPathway.

Matsubara Y. et al, (2026), ESMO Open, 11

Durvalumab Plus Paclitaxel, with or without Capivasertib or Oleclumab, in Patients with Locally Advanced/Metastatic Triple-Negative Breast Cancer.

Schmid P. et al, (2026), Clin Cancer Res

Improved attenuation correction registration for FDG PET/CT images using data-driven gating (DDG)-based motion match.

Wilson Z. et al, (2026), EJNMMI Phys

Understanding how post-intensive care follow-up is delivered within the role of critical care outreach teams: a qualitative study protocol.

Bonner A. et al, (2026), BMJ Open, 16

Proton pencil beam scanning lattice radiotherapy: Technical implementation and comparison against photon-based delivery.

Khalid AS. et al, (2026), Br J Radiol

Radiation dose-dependent skin toxicity and therapeutic advantage of FLASH radiotherapy via immune modulation.

Paillas S. et al, (2026), Int J Radiat Oncol Biol Phys

PHGDH loss promotes hypoxia tolerance through glycolytic reprogramming and enhanced HIF-1 activity

Petrosyan E. et al, (2026), Cell Death Discovery

Coupling dead cell recognition to Fcγ receptors augments anticancer immunity.

Castro-Dopico T. et al, (2026), Nat Cancer

Exosomal survivin as a liquid biopsy biomarker in cancer.

Wijaya W. et al, (2026), J Immunol Methods, 548

Comprehensive Genomic and Transcriptomic Characterization of MTAP Loss Across Advanced Solid Tumors.

Seguchi K. et al, (2026), Clin Cancer Res

Blog posts

Meet Dr Wei-Ting Lu: Exploring Genome Instability in Cancer

Dr Wei-Ting Lu joined the Department of Oncology in September 2025, establishing a research group focused on chromosomal instability and whole genome doubling in cancer. In this blog, Dr Lu shares insights into his lab’s research and the discoveries, both his own and those of others, that sparked his interest in the field.

Beyond the Bench: Lauren's Journey From Cancer Research to Patent Law

After studying the MSc Applied Cancer Science in 2024-2025, Lauren Woodman began her career as a Trainee Patent Attorney. In this blog, she shares her experience of the course and how it inspired her interest in intellectual property law.

International Day of Women and Girls in Science 2026

Today, 11th Feb 2026, is International Day of Women and Girls in Science. To celebrate, our MSc Medical Physics/Radiobiology students honour five pioneering women who shaped nuclear medicine and inspired them on their own journeys in science.

Student Spotlight: Personalised Dosimetry for Radionuclide Therapy

Mark Macsuka is a Clarendon DPhil Scholar in Oncology working on personalised lutetium-177 (177Lu) dosimetry for radionuclide therapies. In this blog, Mark shares insights into the role of AI in cancer treatment and the potential for improved outcomes through personalised treatment approaches.

Staff Spotlight: Working as a Technician in the Translational Support Unit

Sruthi Shakthivel works as a technician in the Translational Support Unit (TSU), a dedicated unit within the Oncology Clinical Trials Office (OCTO) that focuses on the operational and scientific side of biological sample management in clinical trials. In this blog, Sruthi shares insights on the mission of the TSU, how they support clinical research teams, and what her role involves.

Cookies on this website

Search results

Showing results for

Blog posts